High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study.

Xiliang ZhaoQuan LiChenchen TuYong ZengYicong Ye

Published in: Cardiovascular diabetology (2020)

GA could be a potential biomarker to predict the effects of clopidogrel antiplatelet therapy in ACS patients and might be a clinical biomarker to guide DAPT de-escalation.

Keyphrases

antiplatelet therapy
acute coronary syndrome
end stage renal disease
percutaneous coronary intervention
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
pet ct
risk factors
open label